Full Breakdown
White House Considers Erica Schwartz for CDC Leadership
4/15/2026, 8:53:32 AM
Leadership Changes at the CDC
The White House is reportedly considering Erica Schwartz as the new leader of the Centers for Disease Control and Prevention (CDC), according to a report by the Washington Post. Schwartz, a former navy physician, previously served as the deputy U.S. surgeon general during President Donald Trump's first term. Alongside Schwartz, Sean Slovenski, a former executive at Walmart, is being considered for the role of her top deputy, pending Trump's approval.
This potential appointment follows a series of leadership changes at the CDC, which have occurred since the dismissal of former Director Susan Monarez last August. Monarez was removed due to her objections to proposed changes in vaccine policy by Health Secretary Robert F. Kennedy Jr. Following her departure, Jim O'Neill, who was the Deputy Secretary of Health and Human Services (HHS), took over as acting CDC director. O'Neill held this position until February, when he vacated both roles to accept a position as the director of the National Science Foundation. Jay Bhattacharya, the director of the U.S. National Institutes of Health, succeeded O'Neill as acting CDC director.
Key Figures in the Transition
- Erica Schwartz: Former deputy U.S. surgeon general and candidate for CDC director.
- Sean Slovenski: Former Walmart executive, considered for deputy director.
- Susan Monarez: Former CDC director, dismissed over vaccine policy disagreements.
- Jim O'Neill: Former acting CDC director and Deputy Secretary of HHS, now director of the National Science Foundation.
- Jay Bhattacharya: Current acting CDC director and director of the U.S. National Institutes of Health.
Official Statements & Responses
The White House and HHS have not yet commented on the potential appointments. The ongoing leadership changes at the CDC reflect a broader shift in public health policy under the current administration, particularly in response to the COVID-19 pandemic and vaccine distribution strategies.
Criticism & Opposition
The leadership shakeups at the CDC have drawn criticism from various public health experts who argue that frequent changes in leadership can disrupt continuity and effectiveness in managing public health crises. Concerns have been raised regarding the implications of appointing individuals with backgrounds in business rather than public health.
What's Next
As the White House deliberates on these appointments, the public health community is closely monitoring the situation, particularly in light of the upcoming public health challenges and the ongoing response to the COVID-19 pandemic. The final decisions on the CDC leadership are expected to be announced soon, which will likely have significant implications for the agency's direction and policies moving forward.
